W. Chris Taylor
About
In The Last Decade
W. Chris Taylor
8 papers receiving 329 citations
Peers
Comparison fields: 5 of 39
- Geriatrics and Gerontology 195
- Oncology 153
- Physiology 131
- Pulmonary and Respiratory Medicine 92
- Economics and Econometrics 57
Countries citing papers authored by W. Chris Taylor
This map shows the geographic impact of W. Chris Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Chris Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Chris Taylor more than expected).
Fields of papers citing papers by W. Chris Taylor
This network shows the impact of papers produced by W. Chris Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Chris Taylor. The network helps show where W. Chris Taylor may publish in the future.
Co-authorship network of co-authors of W. Chris Taylor
This figure shows the co-authorship network connecting the top 25 collaborators of W. Chris Taylor. A scholar is included among the top collaborators of W. Chris Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Chris Taylor. W. Chris Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 174 | |
| 2 | 87 | |
| 3 | Adjuvant chemotherapy of breast cancer in the older patient. | 4 |
| 4 | 16 | |
| 5 | 3 | |
| 6 | 10 | |
| 7 | 14 | |
| 8 | Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma. | 30 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.